Literature DB >> 11231613

Immune privilege or inflammation? Insights into the Fas ligand enigma.

J O'Connell1, A Houston, M W Bennett, G C O'Sullivan, F Shanahan.   

Abstract

Fas ligand (FasL) has become an enigmatic molecule: some evidence indicates that it contributes to immune privilege in tissues and tumors, whereas other data demonstrates that FasL can elicit inflammation. New findings may begin to reconcile the paradoxical effects of FasL.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11231613     DOI： 10.1038/85395

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  38 in total

1.  Countering the 'counterattack' hypothesis.

Authors:  N P Restifo
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 2.  Fas ligand and the fate of antitumour cytotoxic T lymphocytes.

Authors:  Joe O'Connell
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

3.  Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.

Authors:  Lijun Shen; Anthony C T Liang; Liwei Lu; Wing Yan Au; Yok-Lam Kwong; Raymond H S Liang; Gopesh Srivastava
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.

Authors:  Eiman Adel Hasby
Journal:  Pathol Oncol Res       Date:  2011-12-08       Impact factor: 3.201

5.  Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation-a human biopsy study.

Authors:  Iris Bittmann; Christian Müller; Jürgen Behr; Jan Groetzner; Lorenz Frey; Udo Löhrs
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

6.  Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis.

Authors:  Camia Steinmann; Megan L Landsverk; José M Barral; Darren Boehning
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

7.  Modulation of HLA-G expression in human neural cells after neurotropic viral infections.

Authors:  Monique Lafon; Christophe Prehaud; Françoise Megret; Mireille Lafage; Gaël Mouillot; Michèle Roa; Philippe Moreau; Nathalie Rouas-Freiss; Edgardo D Carosella
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  [Association of FasL-844T/C gene polymorphism with FasL expression in the nucleus pulposus of degenerative lumbar intervertebral discs].

Authors:  Zheng-Ming Sun; Pengmaojiacuo Pengmaojiacuo; Hong-Hai Xu; Yan-Hai Chang; Xue-Yuan Wu; Xiang-Hui Dong; Ming Ling
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

9.  Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.

Authors:  Xiao-Zhong Wang; Xiao-Chun Chen; Yun-Xin Chen; Li-Juan Zhang; Dan Li; Feng-Lin Chen; Zhi-Xin Chen; Hong-Ying Chen; Qi-Ming Tao
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Fas ligand expression in lynch syndrome-associated colorectal tumours.

Authors:  Jan J Koornstra; Steven de Jong; Wietske Boersma-van Eck; Nynke Zwart; Harry Hollema; Elisabeth G E de Vries; Jan H Kleibeuker
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.